AI-CVD vs HealthCCSng

Direct competitors — feature-level head-to-head below. Comparability 88/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI-CVD

by HeartLung Corporation

HealthCCSng

by Nano-X AI

AI Verdict

Both AI-CVD and HealthCCSng are FDA-cleared AI-powered solutions that perform opportunistic screening for cardiovascular risk by analyzing existing CT scans, with a core overlap in coronary artery calcium (CAC) scoring. AI-CVD offers a broader assessment, including cardiac chamber volumetry, epicardial fat analysis, and major vessel sizing, while HealthCCSng specializes in detailed CAC quantification, categorization, and visualization.

Choose AI-CVD if…

Choose AI-CVD if your primary goal is comprehensive, opportunistic screening for a broad range of cardiovascular and multisystem diseases using existing CT scans. This platform is ideal for identifying hidden health risks beyond just coronary artery calcification, offering insights into cardiac chamber volumes, epicardial fat, and aortic health. It's best suited for institutions seeking a holistic view of patient cardiovascular health from routine imaging without additional procedures.

View AI-CVD →

Choose HealthCCSng if…

Choose HealthCCSng if your focus is specifically on the automated and precise detection and quantification of coronary artery calcification (CAC) from routine CT scans. This tool excels at generating clear numerical calcium scores and categorizing patients into risk groups for coronary artery disease. It is particularly well-suited for workflows that require a streamlined, dedicated solution for CAC assessment and risk stratification.

View HealthCCSng →

For a physician evaluating AI tools for cardiovascular risk assessment from CT scans, AI-CVD and HealthCCSng offer distinct advantages. HealthCCSng excels in its focused approach to coronary artery calcification (CAC) analysis. It automatically detects, quantifies, and categorizes CAC from routine non-contrast, non-ECG gated chest CT scans, providing a numerical score and visualization of calcified plaques. This makes it ideal for practices primarily concerned with streamlined, automated CAC assessment and seamless integration into existing PACS and EMR systems for identifying patients at risk of coronary artery disease.

In contrast, AI-CVD provides a broader, multisystem opportunistic screening platform. While it also performs CAC scoring, its key practical difference lies in its ability to offer automated CT-derived anatomical and density-based measurements across various cardiovascular and multisystem diseases. This includes analysis of aortic and mitral valve calcification, cardiac chamber volumetry, epicardial fat volumetry, and aorta and pulmonary artery sizing. Physicians seeking a comprehensive tool for early detection of a wider range of hidden health risks from existing chest and abdominal CT scans, without additional imaging or workflow disruption, would find AI-CVD more suitable.

Therefore, a physician whose primary need is efficient, dedicated coronary artery calcification detection and quantification should lean towards HealthCCSng. Conversely, a physician aiming for a more expansive opportunistic screening solution that covers multiple cardiovascular and multisystem indicators from existing CT data would benefit more from AI-CVD’s broader analytical capabilities.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI-CVD	HealthCCSng
Pricing	Contact for pricing	Not publicly available
Deployment	Cloud	Cloud-based, integrates with PACS and EMR systems
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

HealthCCSng

Both tools emphasize seamless integration and minimal workflow disruption. However, HealthCCSng explicitly highlights 'seamless integration with PACS and EMR systems' and 'automated workflow for results without human intervention,' which are strong indicators of a highly usable and efficient solution for clinical environments.

Clinical Value

AI-CVD

AI-CVD offers a broader range of opportunistic screening capabilities beyond just coronary artery calcification (CAC), including aortic wall and valve calcium, cardiac chamber volumetry, epicardial fat volumetry, and aorta/pulmonary artery sizing. This allows for a more comprehensive assessment of cardiovascular and multisystem disease risks from existing CT scans.

Pricing & Value

Tie

Neither AI-CVD nor HealthCCSng provides publicly available pricing information. Both require contacting the vendor for details, making it impossible to compare their pricing structures or assess their relative value proposition without further information.

Enterprise Readiness

HealthCCSng

Both tools are FDA-cleared and cloud-deployed. HealthCCSng explicitly states HIPAA compliance and seamless integration with PACS and EMR systems, which are critical for enterprise adoption and data management. AI-CVD states HIPAA compliance is 'likely' but less definitive.

Innovation

AI-CVD

While both utilize AI for opportunistic screening, AI-CVD demonstrates greater innovation by offering a more expansive suite of measurements for cardiovascular and multisystem diseases, including cardiac chamber volumetry, epicardial fat, and other systemic indicators from a single CT scan. This broader approach to extracting comprehensive health insights is more innovative than a sole focus on CAC.

Support & Docs

Tie

Neither the provided structured facts nor available public web searches offer specific details regarding the support services, documentation, or training resources for either AI-CVD or HealthCCSng. Therefore, a meaningful comparison on this dimension is not possible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI-CVD	HealthCCSng
Name	AI-CVD	HealthCCSng
Company	HeartLung Corporation	Nano-X AI
Description	FDA-cleared, AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks.	FDA-cleared AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease.
Key Features (CAC Scoring)	Coronary Artery Calcium (CAC) scoring	Automatically detects and quantifies coronary artery calcification (CAC); Categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories; Generates a numerical calcium score; Provides visualization of calcified plaques within coronary arteries
Additional Key Features	Automated CT-derived anatomical and density-based measurements; Opportunistic screening from existing chest and abdominal CT scans; No additional imaging, radiation, contrast, or workflow disruption; Aortic wall, aortic valve, and mitral valve calcium analysis; Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle); Epicardial fat volumetry; Aorta and pulmonary artery sizing	Analyzes non-contrast, non-ECG gated chest CT scans; Seamless integration with PACS and EMR systems; Automated workflow for results without human intervention; Customizable CAC category configuration

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and HealthCCSng.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in the scope of disease detection between AI-CVD and HealthCCSng?

AI-CVDu00ae is a comprehensive platform designed for opportunistic screening of cardiovascular and multisystem diseases, offering automated measurements for coronary artery calcium (CAC), aortic wall, aortic valve, mitral valve calcium, cardiac chamber volumetry, epicardial fat volumetry, and aorta and pulmonary artery sizing. HealthCCSng, while also performing CAC scoring, is primarily focused on automatically detecting and quantifying coronary artery calcification to identify patients at risk of coronary artery disease.

How do these tools integrate into existing clinical workflows and what is their impact on workflow disruption?

HealthCCSng offers seamless integration with PACS and EMR systems and provides an automated workflow for results without human intervention. AI-CVDu00ae emphasizes that it uses existing CT scans and requires no additional imaging, radiation, contrast, or workflow disruption.

What types of CT scans are compatible with each AI tool for analysis?

AI-CVDu00ae performs opportunistic screening using existing chest and abdominal CT scans. HealthCCSng analyzes routine, non-contrast, non-ECG gated chest CT scans to detect and quantify coronary artery calcification.

What specific details and categorizations do these tools provide for coronary artery calcification (CAC) results?

HealthCCSng automatically detects and quantifies CAC, categorizing studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, generates a numerical calcium score, and provides visualization of calcified plaques within coronary arteries. It also allows for customizable CAC category configuration. AI-CVDu00ae also performs Coronary Artery Calcium (CAC) scoring as one of its key features.